Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Hartwig

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Trends in Biochemical Sciences|December 3, 2017
Paving TRAIL's Path with UbiquitinElodie Lafont, Torsten Hartwig, Henning Walczak
Brain Research|December 6, 2008
The Kv1.2 potassium channel: the position of an N-glycan on the extracellular linkers affects its protein expression and functionJing Zhu, Esperanza Recio-Pinto, Torsten Hartwig, et al.
The EMBO Journal|March 5, 2017
The linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell deathElodie Lafont, Chahrazade Kantari-Mimoun, Peter Draber, et al.
Cell Death & Disease|August 1, 2021
TRAIL-receptor 2-a novel negative regulator of p53Anna Willms, Hella Schupp, Michelle Poelker, et al.
Cell Reports|December 17, 2015
LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling ComplexesPeter Draber, Sebastian Kupka, Matthias Reichert, et al.
Molecular Cell|February 19, 2017
The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2Torsten Hartwig, Antonella Montinaro, Silvia von Karstedt, et al.
The Journal of Experimental Medicine|November 5, 2016
--LUBAC deficiency perturbs TLR3 signaling to cause immunodeficiency and autoinflammationJulia Zinngrebe, Eva Rieser, Lucia Taraborrelli, et al.
Nature Communications|September 27, 2018
LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95LLucia Taraborrelli, Nieves Peltzer, Antonella Montinaro, et al.
Nature|April 27, 2018
LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesisNieves Peltzer, Maurice Darding, Antonella Montinaro, et al.
Cancer Cell|April 7, 2015
Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasisSilvia von Karstedt, Annalisa Conti, Max Nobis, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Trends in Biochemical Sciences|December 3, 2017
Paving TRAIL's Path with UbiquitinElodie Lafont, Torsten Hartwig, Henning Walczak
Brain Research|December 6, 2008
The Kv1.2 potassium channel: the position of an N-glycan on the extracellular linkers affects its protein expression and functionJing Zhu, Esperanza Recio-Pinto, Torsten Hartwig, et al.
The EMBO Journal|March 5, 2017
The linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell deathElodie Lafont, Chahrazade Kantari-Mimoun, Peter Draber, et al.
Cell Death & Disease|August 1, 2021
TRAIL-receptor 2-a novel negative regulator of p53Anna Willms, Hella Schupp, Michelle Poelker, et al.
Cell Reports|December 17, 2015
LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling ComplexesPeter Draber, Sebastian Kupka, Matthias Reichert, et al.
Molecular Cell|February 19, 2017
The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2Torsten Hartwig, Antonella Montinaro, Silvia von Karstedt, et al.
The Journal of Experimental Medicine|November 5, 2016
--LUBAC deficiency perturbs TLR3 signaling to cause immunodeficiency and autoinflammationJulia Zinngrebe, Eva Rieser, Lucia Taraborrelli, et al.
Nature Communications|September 27, 2018
LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95LLucia Taraborrelli, Nieves Peltzer, Antonella Montinaro, et al.
Nature|April 27, 2018
LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesisNieves Peltzer, Maurice Darding, Antonella Montinaro, et al.
Cancer Cell|April 7, 2015
Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasisSilvia von Karstedt, Annalisa Conti, Max Nobis, et al.
Pageof 1